Innovation and Cell Targeting Group

The GICC consists of the expertise of molecular biologists, geneticists, haematologists, immunologists, pharmacologists, chemists and clinicians.

Our research focuses on the pathophysiological mechanisms of cancers (leukemia, glioma, cancers of the digestive tract) and inflammatory or immunological diseases, in order to set up and personalise new therapeutics.